Biotechnology

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Biotechnology
Apr 25, 2025, 20:27 | Blog
Daniel Chen and Synthetic Design Lab announce $20M launch to advance ADC innovation
Daniel Chen, Founder and CEO of Synthetic Design Lab, shared a post on LinkedIn by…
Mar 5, 2025, 07:26 | Oncolibrary
New Paper Alert: Silver nanoparticle induced immunogenic cell death can improve immunotherapy
This study demonstrates the potential of silver nanoparticles (Ag-citrate-5 nm) as an immunomodulatory agent to…
Feb 25, 2025, 15:10 | Science
Wafaa M Rashed: Genomic Innovation for Economic Development
Wafaa M Rashed, Faculty Lecturer of pharmacy at Ahram Canadian University, shared a post on…
Dec 29, 2024, 10:00 | Drugs
Giannis Mountzios: 10 exciting compounds that will shape lung cancer in 2025
Giannis Mountzios, Consultant Medical Oncologist at the Department of Medical Oncology in the Air force…
Dec 22, 2024, 05:22 | Insight
Camilla Perucchini: I have officially graduated with a Master of Science in Biotechnology curriculum
Camilla Perucchini, Clinical Study Coordinator at IFO - Istituto Nazionale Tumori Regina Elena - Istituto…
Dec 3, 2024, 17:34 | Blog
Calling all Paediatric and Maternal Health Innovators - i4KIDS-EUROPE
i4KIDS I i4KIDS-EUROPE shared a post on LinkedIn: "Calling all Paediatric and Maternal Health Innovators.…
Nov 8, 2024, 12:37 | Positive
Jennifer Buell: Pioneering Leadership in Biotechnology
Dr. Jennifer Buell is a prominent figure in the biotechnology industry, currently serving as the…
Oct 30, 2024, 09:47 | Insight
AI Hype and Reality - Three scientists go on a hike in Deep Origin
Three chemists head on a hike and discuss the realistic short term effects of AI…
Oct 24, 2024, 15:14 | Blog
Maria Babak: Wishing CityU iGEM team all the best!
Maria (Masha) Babak reposted the a post by The Babak Lab on LinkedIn, adding the…
Jul 8, 2024, 12:29 | Drugs
Jennifer Buell: NCI Announces Availability of Botensilimab for Clinical Development
Jennifer Buell, President and Chief Executive Officer of MiNK Therapeutics, shared on X: “NCI Announces…
Jun 18, 2024, 23:25 | Insight
The future of immuno-oncology discussion with Agenus at ESMO GI 2024
Agenus shared a post on LinkedIn: “Are you a physician attending ESMO GI 24? Join…
Jun 14, 2024, 06:30 | Blog
David Fajgenbaum: So great to connect with so many leaders last week at I Am Biotech!
David Fajgenbaum, Associate Professor of Medicine at University of Pennsylvania School of Medicine, shared on X:…
May 17, 2024, 14:37 | Blog
Sheo Mohan Singh: Celebrating with summer training participants
Sheo Mohan Singh, Director at International Centre for Stem Cells, Cancer and Biotechnology (ICSCCB) shared…
May 15, 2024, 10:13 | Blog
Patient dosing has commenced in the Phase 1 clinical trial of SENTI-202 - Senti Biosciences
Tim Lu, Co-Founder and CEO at Senti Biosciences, shared the following post by Senti Biosciences…
May 15, 2024, 08:32 | Blog
Tanja Obradovic: Private Biotech investment is on the steady rise reaching $3.1 billion in April
Tanja Obradovic, Vice President of  Oncology Scientific Affairs at ICON, shared on LinkedIn: “Private Biotech investment is…
Apr 27, 2024, 08:15 | Blog
Jacqueline Hess: Highlights coming out of Swiss Biotech Day 2024
Jacqueline Hess, Chair (Switzerland) of The Boardroom, shared on LinkedIn: “There are always many highlights…
Feb 28, 2024, 15:03 | Blog
Cristina Jauset Gonzalez: Flagship Pioneering's newest stealth biotech start-up, FL102, is looking for its first two scientists!
Cristina Jauset Gonzalez, Associate at Flagship Pioneering, made the following post on LinkedIn: "Flagship Pioneering's…
Feb 17, 2024, 19:19 | Blog
Don't miss out on two remarkable Keynotes at Moffitt's Business of Biotech Conference next Friday, Feb 23! - Moffitt Cancer Center
Moffitt Cancer Center shared on LinkedIn: “Don't miss out on two remarkable Keynotes at Moffitt's Business…
Jan 27, 2024, 22:42 | Blog
John Houston: Thanks for the great write up on the exciting events happening at Arvinas!
John Houston, Chairperson, CEO and President at Arvinas (NASDAQ ARVN), shared the following post by…
Oct 31, 2023, 23:29 | Blog
We’re excited to announce our new strategic partnership with Verily - Georgiamune Inc.
Georgiamune Inc. made the following post on LinkedIn: "We’re excited to announce our new strategic…
Oct 31, 2023, 10:23 | Blog
Harout Semerjian: It was an honor to be appointed to the Biotechnology Innovation Organization’s Board of Directors, Emerging Companies Section
Harout Semerjian, President and CEO at GlycoMimetics, posted on LinkedIn: "It was an honor this…
Oct 11, 2023, 22:39 | Opinion
Agenus completed the planned patient enrollment of its Phase 2 clinical trial evaluating investigational agents botensilimab (BOT) and balstilimab (BAL) in advanced colorectal cancer. - Agenus
All: 22 Posts: 1 - 100
Special Coverage